PROTAC BTK Degrader-11

Target: This ligand targets Bruton tyrosine kinase (BTK) in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for Bruton tyrosine kinase (BTK). In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings Bruton tyrosine kinase (BTK) into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• BTK-Directed PROTAC Design: PROTAC BTK Degrader-11 can be used to build and optimize chimeric molecules that recruit BTK to an E3 ligase, enabling ubiquitination and proteasomal degradation. Researchers can evaluate linker length, attachment sites, and dosing schedules to maximize BTK turnover while minimizing off-target effects and maintaining cellular engagement.

• Signal Pathway Degradation Studies: Use this BTK-targeting degrader to probe how BTK removal reshapes downstream signaling networks in B-cell receptor and related pathways. By comparing degradation kinetics to phosphorylation and transcriptional readouts, experiments can distinguish degradation-dependent effects from transient inhibition, supporting mechanistic studies of pathway rewiring.

• E3 Ligase Recruitment Optimization: The degrader format supports systematic testing of E3 ligase recruiter compatibility and ternary complex formation with BTK. Researchers can vary E3 ligase ligands or co-expression conditions to enhance productive ubiquitination, then quantify degradation potency and selectivity using immunoblotting, flow cytometry, and proteomics.

• Resistance and Selectivity Profiling: Apply PROTAC BTK Degrader-11 to investigate degradation robustness under conditions that may reduce inhibitor efficacy, such as altered BTK expression or signaling compensation. Parallel profiling across kinases and BTK mutants can map selectivity determinants and identify features that sustain degradation despite adaptive resistance mechanisms.

• Target Engagement and Kinetics: Employ this BTK degrader to measure target engagement and degradation kinetics across time and concentration. Using time-course experiments, researchers can correlate BTK occupancy with degradation half-life, explore threshold behavior, and refine experimental windows for downstream functional assays, including apoptosis, proliferation, and cytokine production.

PROTAC BTK Degrader-11 is a BTK kinase target ligand intended for use as the target-engaging component or reference ligand in PROTAC discovery workflows. Its known small-molecule recognition profile enables rational linker-vector evaluation and comparative degrader design. This molecule is described in detail below.

Structure: The structure of PROTAC BTK Degrader-11 is characterized by primary or secondary amine/basic nitrogen centers; amide/urea/sulfonamide hydrogen-bonding motifs; heteroaromatic protein-recognition scaffold. These features provide defined hydrogen-bonding, hydrophobic, and steric elements that can support affinity retention while enabling analogue-based linker-vector selection.

Reactivity: The amine/basic nitrogen-containing motif can be evaluated for acylation, sulfonylation, alkylation, or carbamate/urea linker installation when that vector is solvent exposed. For PROTAC construction, the POI ligand can be paired with CRBN ligands such as thalidomide, pomalidomide, or lenalidomide analogues, VHL ligands such as VH032 derivatives, or less common IAP/MDM2/cIAP-recruiting ligands, with alkyl, PEG, piperazine, triazole, or amide linkers screened for ternary-complex formation. In practice, incorporation into PROTACs should begin from derivatives that preserve the reported binding pharmacophore, followed by systematic variation of linker length, polarity, rigidity, and exit-vector geometry to optimize target engagement, E3 recruitment, and cellular degradation readouts.